← Mechanisms of action
Human immunodeficiency virus
ORGANISMHuman immunodeficiency virus
Drugs acting on this target (250)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| lenacapavir (Sunlenca) | Antagonist | approved | Small molecule | Human immunodeficiency virus antagonist |
| ad26.enva.01 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad35 investigational hiv vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad35-env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad35-grin | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad35-grin/env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad4-env145nfl | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad4-env150kn | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad4-envcn54 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad4-mgag | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad5-gag | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ad5.enva.48 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| aeras-456 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| afo-18 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ags-004 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| aidsvax b/e | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| apl 400-003 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| autologous cd34+ hematopoietic progenitor cells transduced with anti-hiv-1 ribozyme | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| autologous hiv-1 apb dc vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| avx101 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| b63521^11 gp120 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| bg505 sosip.664 gp140 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| c46/ccr5/p140k lentiviral vector-transduced autologous hspcs | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ch505tf gp120 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ch505w100 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| chadox1.hti | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| clade b gag dna/plg and env dna/plg microparticles | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| clade b hiv vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| clade b recombinant, oligomeric gp140/mf59 adjuvant | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| clade c gp140 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| cn54env dna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| cn54gp140 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ctl mep/rc529-se/gm-csf | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dc+hiv-at2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dcv3 | Immunity, active | experimental | Cell therapy | Human immunodeficiency virus immunity, active |
| dendritic cells pulsed with hiv antigens | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna con-s env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna mosaic env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna mosaic-tre | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna nat-b env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna prime | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna-ad vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna-c cn54env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna-c2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna-hiv-pt123 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna.hiva | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| dna.hti | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| en41-fpa2 hiv vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| en41-ugr7c hiv vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| env (a,b,c,a/e)/gag (c) dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| env 2-3 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| envdna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| envpro | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ep hiv-1043 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ep hiv-1090 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ep-1233 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ep1090 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| geo-d02 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| geo-d03 dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| glycoprotein 140 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gp120 (a,b,c,a/e) protein vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gp140 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gp145 c.6980 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gp160 mn/lai-2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gp160 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gsk732461 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gtu-multhiv b vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| gx-12 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv clade b'/c dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv dna plasmid vaccine plus recombinant fowlpox vector | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv gag-pol antigens | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv glycoprotein 140 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv glycoprotein cn54gp140 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv gp120/neftat/as02a vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv lfn-p24 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv mrna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv p17/p24:ty-vlp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv vaccine 732461 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 c4-v3 polyvalent peptide vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 delta-v2 env vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 dna plasmid vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 gag dna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 gp 160 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 nef/tat/vif, env pdna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 peptide immunogen, multivalent | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 peptide vaccine, microparticulate monovalent | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 recombinant ad5 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 tat vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 tat/delta-v2 env combined vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-1 trimeric gp140 env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-gag mrna-pulsed autologous dcs | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-mag | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hiv-rad5 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hivac-1e | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hivacar01 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hivax | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| hivis dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| human immunodeficiency virus glycoprotein 140 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ihivarna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ihv01 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| inactivated hiv | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| ino-6145 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| js7 plasmid dna | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| killed-whole hiv-1 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| lc002 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| lipo-4 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| lipo-5 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| lipo-5 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mgmtp140k | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mn rgp120/hiv-1 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| modified vaccinia ankara hiv vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mosaic gp140 env trimers | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mper-656 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mrkad5 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mrkad5 hiv-1 gag/pol/nef | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-c | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-cmdr | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-cn54 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-hiv62 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-mbn120b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-mbn32 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-mosaic | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva-nef | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva.hiva | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva.hivconsv | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva.hti | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva/hiv62b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mva62b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mvatg17401 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mydc | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| mym-v101 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac con-s env vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac mosaic env vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac nat-b env vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac-b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac-c | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac-hiv-pt1 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| nyvac-hiv-pt4 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| opal-hiv-gag(c) | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| p24ce1/2 pdna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| p3c541b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| p55^gag pdna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pclus 3-18 mn | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pclus 6.1 mn | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pennvax-b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pennvax-g dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pga2/js2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| pga2/js7 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| phis-hiv-ae | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| polyenv1 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| profectus hiv mag pdna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| protein/mf59 | Immunity, active | experimental | Small molecule | Human immunodeficiency virus immunity, active |
| psg2.hivconsv dna vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| raav1-pg9dp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rad35 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rad5 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rad5 gag-pol | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rad5 gag-pol env a/b/c | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rc529-se | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rcad26.mos1.hiv-env | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| recombinant fowlpoxvirus expressing hiv gag-pol antigens | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| recombinant hiv-1 tat protein | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| revm10 gene | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| revm10/polas gene | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rfpv-hiv | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rgp120/hiv-1 sf-2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rgp120/hiv-1iiib | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rmva-hiv | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| rvsv hiv envc vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| saavi dna-c2 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| saavi mva-c vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| salmonella typhi cvd 908-hiv-1 lai gp 120 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| sev-g(np) | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tat oyi | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tat/rev/nef-rt | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tbc-3b | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tbc-m4 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tbc-mva | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| tgaac09 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| thv01-2 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| trivalent mrkad5 hiv-1 gag/pol/nef | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| v205 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| v520 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vac-3s | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vacc-4x | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vacc-c5 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vcp125 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vcp1433 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vcp1452 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vcp205 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vcr-hivdna006-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc rad5 vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-diluent013-dil-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivadv027-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivadv038-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivdna-016-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivdna009-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivdna044-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivmab075-00-ab | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc-hivrgp096-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrc4302 | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vrchivadv014-00-vp | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vsv hiv gag vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| vsv-indiana hiv gag vaccine | Immunity, active | experimental | Vaccine | Human immunodeficiency virus immunity, active |
| aav8-vrc07 | Immunity, passive | experimental | Gene therapy | Human immunodeficiency virus immunity, passive |
| cal-1 modified hspc | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| hiv 1 antigen expanded specific t cell | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| hiv ctl mep | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| hiv-1 specific car-t cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| hiv-specific cd8 cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| hiv-specific t cell | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| lvsh5/c46 (cal-1) transduced cd34+ hematopoietic stem cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| mb66 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| mgd014 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| p2g12 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| pehrg214 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| pgdm1400 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| pgt121 | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| phiv7-shi-tar-ccr5rz treated cd4 cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| sb-728-t | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| shRNA-modified CD34+ cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| suvizumab | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| vrc-hivmab060-00-ab | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| vrc-hivmab080-00-ab | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| vrc-hivmab95-00-ab | Immunity, passive | experimental | mAb | Human immunodeficiency virus immunity, passive |
| wt-gag-tcr modified t cells | Immunity, passive | experimental | Cell therapy | Human immunodeficiency virus immunity, passive |
| autologous stem cells transduced with facc retroviral vector | Inhibitor | experimental | Gene therapy | Human immunodeficiency virus inhibitor |
| bms-626529 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| cal-1 (lvsh5/c46) | Inhibitor | experimental | Gene therapy | Human immunodeficiency virus inhibitor |
| calanolide a | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| ci-1012 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| dexelvucitabine | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| dinitrochlorobenzene | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| enfuvirtide (fuzeon) | Inhibitor | approved | Peptide | Human immunodeficiency virus inhibitor |
| gp120w61d | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| gsk3640254 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| he2000 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| iqp-0528 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| letrazuril | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| mk-1972 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| mk-4250 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| mk-8504 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| mk-8558 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| mk-8583 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| pf-06273588 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| s-648414 | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| steviolbioside | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| tifuvirtide | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |
| zintevir | Inhibitor | experimental | Small molecule | Human immunodeficiency virus inhibitor |